Abstract 1324: NMS-P088, a novel FLT3, KIT and CSF1R inhibitor, is a promising clinical candidate for AML and CMML treatment von Ciomei, Marina, Ardini, Elena, Gianellini, Laura, Borleri, GianMaria, Romero, Gemma Texido, Ceruti, Roberta, Pastori, Wilma, Avanzi, Nilla, Casero, Daniele, Gnocchi, Paola, Borgia, Andrea Lombardi, Lussana, Federico, Rambaldi, Alessandro, Galvani, Arturo, Isacchi, Antonella

Volltext